eIF4E orchestrates mRNA processing, RNA export and translation to modify specific protein production

• DOI: 10.1080/19491034.2024.2360196
• Publication Date: 2024-06-17T04:23:49Z
• Authors: Jean-Clément Mars; Biljana Culjkovic...; Katherine L.B. Bo...
• Keywords: Cap binding protein; mRNA export; 0301 basic medicine; QH573-671; capping; m7G cap; Review; QH426-470; RNA Transport; 03 medical and health sciences; Eukaryotic Initiation Factor-4E; eIF4E; Protein Biosynthesis; gene expression; Genetics; Humans; Animals; RNA, Messenger; RNA Processing, Post-Transcriptional; Cytology

The eukaryotic translation initiation factor eIF4E acts as a multifunctional factor that simultaneously influences mRNA processing, export, and translation in many organisms. Its multifactorial effects are derived from its capacity to bind to the methyl-7-guanosine cap on the 5'end of mRNAs and thus can act as a cap chaperone for transcripts in the nucleus and cytoplasm. In this review, we describe the multifactorial roles of eIF4E in major mRNA-processing events including capping, splicing, cleavage and polyadenylation, nuclear export and translation. We discuss the evidence that eIF4E acts at two levels to generate widescale changes to processing, export and ultimately the protein produced. First, eIF4E alters the production of components of the mRNA processing machinery, supporting a widescale reprogramming of multiple mRNA processing events. In this way, eIF4E can modulate mRNA processing without physically interacting with target transcripts. Second, eIF4E also physically interacts with both capped mRNAs and components of the RNA processing or translation machineries. Further, specific mRNAs are sensitive to eIF4E only in particular mRNA processing events. This selectivity is governed by the presence of cis-acting elements within mRNAs known as USER codes that recruit relevant co-factors engaging the appropriate machinery. In all, we describe the molecular bases for eIF4E's multifactorial function and relevant regulatory pathways, discuss the basis for selectivity, present a compendium of ~80 eIF4E-interacting factors which play roles in these activities and provide an overview of the relevance of its functions to its oncogenic potential. Finally, we summarize early-stage clinical studies targeting eIF4E in cancer.